Navigation Links
Predicting The Risk Of A Heart Attack

A certain biomarker in the blood may predict the risk of heart attack or death for patients with coronary heart disease //, according to a new study.

Researchers conducted a study to determine whether blood levels of placental growth factor (PIGF) can predict risk for death or non-fatal heart attack in patients with acute chest pain. PIGF is a member of the vascular growth factor family and it acts as an instigator of hardening and narrowing of the arteries. Researchers took various measurements from 547 patients with acute coronary syndrome (ACS) and 626 patients who visited emergency rooms complaining of chest pain.

The researchers found that in patients with ACS, elevated PIGF levels indicated a higher rate of non-fatal heart attacks or death. It was seen that, patients with elevated levels were more than three-times more likely to experience these cardiac events than patients without elevated levels. In patients with acute chest pains, those with high PIGF levels were also at significantly increased risk compared with patients with low PIGF levels.

Researchers conclude that PIGF blood levels are valuable predictors of outcomes in patients with known or suspected ACS. They also say that, “PIGF plasma levels represent a potentially powerful clinical biomarker of vascular inflammation and adverse outcomes in patients with ACS.”

Thus Measuring PIGF levels may extend the predictive and prognostic information gained from traditional inflammatory markers.

Page: 1

Related medicine news :

1. Predicting The Risk Of Preeclampsia During Pregnancy
2. Predicting Severity Of Appendicitis With Computed Tomography
3. Predicting The Risk Of Breast Cancer In The Future
4. Predicting The Risk Of Osteoarthritis
5. Predicting Breast Cancer Recurrence By Understanding Gene Signature
6. Researchers Find Mix of Biomarkers Predicting Mortality
7. Biomarkers Predicting Mortality Found Using Statistical Technique
8. HIV RNA Level Seen As Little Value In Predicting Treatment
9. Predicting the Dynamics of Clotting in Human Blood
10. Follicle Count Test as Good as Hormone Tests in Predicting Ovarian Response
11. One in Three Heart Attack Patients Have No Chest Pains
Post Your Comments:

(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: